Publications

Publications

Scientific contributions highlighting the impact of Diatech Pharmacogenetics technologies in diagnostics.

Filter

All years 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2008
All product lines Easy Easy PGX Helix Microsatelliti Myriapod Myriapod NGS Realquant Response
  • Easy

Real-world data on treatment outcomes in EGFR-mutant non-small-cell lung cancer patients receiving osimertinib in second or further lines.

  • Response

High BRAF variant allele frequencies are associated with distinct pathological features and responsiveness to target therapy in melanoma patients.

  • Response

Incidence, clinicopathologic, and genetic characteristics of mismatch repair gene-mutated glioblastomas

  • Easy PGX

Combination of ultrasound and molecular testing in malignancy risk estimate of Bethesda category IV thyroid nodules: results from a single-institution prospective study

  • Easy PGX

The Molecular Landscape of Primary Acral Melanoma: A Multicenter Study of the Italian Melanoma Intergroup (IMI).

  • Easy PGX, Myriapod NGS

Dealing with NSCLC EGFR mutation testing and treatment: A comprehensive review with an Italian real-world perspective.

  • Myriapod

Molecular profiling of appendiceal serrated lesions, polyps and mucinous neoplasms: a single-centre experience

  • Easy PGX

The Roadmap of Colorectal Cancer Screening

  • Easy

Fine-Needle Aspiration Cytology and Histological Types of Thyroid Cancer in the Elderly: Evaluation of 9070 Patients from a Single Referral Centre

  • Myriapod

Combined use of 177Lu-DOTATATE and metronomic capecitabine (Lu-X) in FDG-positive gastro-entero-pancreatic neuroendocrine tumors

Your next step starts here. Fill out the form and talk to us

Let's talk